CH662812A5 - Compositions injectables renfermant du metronidazole. - Google Patents

Compositions injectables renfermant du metronidazole. Download PDF

Info

Publication number
CH662812A5
CH662812A5 CH3960/84A CH396084A CH662812A5 CH 662812 A5 CH662812 A5 CH 662812A5 CH 3960/84 A CH3960/84 A CH 3960/84A CH 396084 A CH396084 A CH 396084A CH 662812 A5 CH662812 A5 CH 662812A5
Authority
CH
Switzerland
Prior art keywords
weight
particles
metronidazole
microns
suspension according
Prior art date
Application number
CH3960/84A
Other languages
English (en)
French (fr)
Inventor
John Howard Bell
Robert Paul Haslam
Andrew Lewis
Original Assignee
May & Baker Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by May & Baker Ltd filed Critical May & Baker Ltd
Publication of CH662812A5 publication Critical patent/CH662812A5/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CH3960/84A 1983-08-19 1984-08-17 Compositions injectables renfermant du metronidazole. CH662812A5 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838322364A GB8322364D0 (en) 1983-08-19 1983-08-19 Compositions of matter

Publications (1)

Publication Number Publication Date
CH662812A5 true CH662812A5 (fr) 1987-10-30

Family

ID=10547557

Family Applications (1)

Application Number Title Priority Date Filing Date
CH3960/84A CH662812A5 (fr) 1983-08-19 1984-08-17 Compositions injectables renfermant du metronidazole.

Country Status (17)

Country Link
JP (1) JPS6067468A (da)
AU (1) AU577055B2 (da)
BE (1) BE900381A (da)
CA (1) CA1214727A (da)
CH (1) CH662812A5 (da)
DE (1) DE3430354A1 (da)
DK (1) DK165817C (da)
FR (1) FR2560043B1 (da)
GB (2) GB8322364D0 (da)
HU (1) HU192990B (da)
IL (1) IL72714A (da)
IT (1) IT1213208B (da)
LU (1) LU85511A1 (da)
NL (1) NL8402510A (da)
NZ (1) NZ209270A (da)
SE (1) SE460095B (da)
ZA (1) ZA846431B (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU205861B (en) * 1986-12-19 1992-07-28 Sandoz Ag Process for producing hydrosole of pharmaceutically effective material
US7849856B2 (en) 2001-06-25 2010-12-14 3M Innovative Properties Company Respirator valve

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB213928A (en) * 1923-04-06 1925-07-02 Deutsche Werke Ag Improvements in or relating to compensated induction motors for single or polyphase alternating current
US3457348A (en) * 1966-06-27 1969-07-22 American Cyanamid Co Stable syringeable suspensions of parenteral drugs in complex floc form
GB1430411A (en) * 1973-04-05 1976-03-31 May & Baker Ltd Method and compositions for combating swine dysentery
US4029782A (en) * 1975-04-28 1977-06-14 Eli Lilly And Company Cefazolin suspension for parenteral administration
GB2000025A (en) * 1977-05-14 1979-01-04 Pfizer Ltd Nitroimidazole formulations
DE2932691A1 (de) * 1979-08-11 1981-04-09 Bayer Ag, 5090 Leverkusen Antimykotische mittel mit hoeherer freisetzung der wirkstoffe

Also Published As

Publication number Publication date
DK397084D0 (da) 1984-08-17
DK397084A (da) 1985-02-20
JPS6067468A (ja) 1985-04-17
BE900381A (fr) 1985-02-18
DK165817B (da) 1993-01-25
FR2560043B1 (fr) 1988-08-05
GB8420959D0 (en) 1984-09-19
GB2145088B (en) 1986-10-08
LU85511A1 (fr) 1985-04-24
SE8404130L (sv) 1985-02-20
IT8422323A0 (it) 1984-08-13
FR2560043A1 (fr) 1985-08-30
ZA846431B (en) 1985-03-27
CA1214727A (en) 1986-12-02
SE8404130D0 (sv) 1984-08-17
GB8322364D0 (en) 1983-09-21
DK165817C (da) 1993-06-21
IT1213208B (it) 1989-12-14
AU3202284A (en) 1985-02-21
NL8402510A (nl) 1985-03-18
AU577055B2 (en) 1988-09-15
NZ209270A (en) 1988-02-29
DE3430354A1 (de) 1985-03-07
HUT35650A (en) 1985-07-29
HU192990B (en) 1987-08-28
IL72714A (en) 1988-09-30
SE460095B (sv) 1989-09-11
GB2145088A (en) 1985-03-20

Similar Documents

Publication Publication Date Title
CA2233924C (fr) Nouvelles formulations liquides stables a base de paracetamol et leur mode de preparation
EP1242047B1 (fr) Formulations galeniques du fenofibrate et leur procede d'obtention
EP0835105B1 (fr) Composition pharmaceutique d'amiodarone pour administration parenterale
FR2761265A1 (fr) Composition pharmaceutique pour l'administration orale d'un derive du n-piperidino-3-pyrazolecarboxamide, de ses sels et de leurs solvates
FR2853547A1 (fr) Compositions pharmaceutiques injectables contenant de la piperacilline et du tazobactame, et procede pour leur production
EP1207875B1 (fr) Preparation pharmaceutique stable d'oxaliplatine pour administration par voie parenterale
EP4429634A1 (fr) Solution pharmaceutique d'hydrocortisone pour dispositif d'injection
WO2011036357A2 (fr) Formulation liquide, stable, prete a l'emploi de ketoprofene
CH662812A5 (fr) Compositions injectables renfermant du metronidazole.
EP0941090A1 (fr) Compositions pharmaceutiques contenant des derives de n-sulfonyl indoline
WO2015068105A1 (en) An improved process for manufacturing sterile ophthalmic pharmaceutical suspensions
WO2004010977A1 (fr) Procede pour diminuer la variabilite de la biodisponibilite d'un medicament a administration orale
JP6189437B2 (ja) 注射用抗生物質製剤およびその使用方法
EP0433140B1 (fr) Nouvelle préparation pharmaceutique anti-allergique à action prolongée
WO2008099068A2 (fr) Composition liquide anhydre destinee a etre incorporee a l'eau de boisson des animaux d'elevage
FR3057771A1 (fr) Emulsions topiques de lidocaine et d'acides gras utiles en tant qu'analgesique, antalgique ou retardant sexuel
Jigar et al. Development of stable multiple emulsion of atorvastatin
WO2001066109A1 (fr) Compositions pharmaceutiques orales contenant des derives de n-sulfonylindoline
EP2938326A1 (fr) Nouvelles compositions pharmaceutiques veterinaires et leur procede de preparation
FR2793418A1 (fr) Formulations galeniques d'agents antithrombotiques pour administration sous-cutanee
FR2793412A1 (fr) Formulations galeniques d'argatroban pour administration sous-cutanee
CH397955A (fr) Procédé de fabrication d'une préparation corticotropique à action prolongée

Legal Events

Date Code Title Description
PL Patent ceased